estrone has been researched along with em 800 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellavance, E; Luu-The, V; Poirier, D | 1 |
| Belanger, A; Gauthier, S; Labrie, C; Labrie, F; Luo, S; Martel, C; Mérand, Y; Sourla, A | 1 |
| Labrie, C; Labrie, F; Luo, S; Stojanovic, M | 1 |
| Bélanger, A; Candas, B; Couillard, S; Gutman, M; Labrie, C; Labrie, F | 1 |
| Bélanger, A; Candas, B; Gauthier, S; Labrie, C; Labrie, F; Li, X; Martel, C; Mérand, Y; Provencher, L | 1 |
| Bélanger, A; Candas, B; Couillard, S; Labrie, C; Labrie, F; Pouliot, F | 1 |
6 other study(ies) available for estrone and em 800
| Article | Year |
|---|---|
Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
Topics: 17-Hydroxysteroid Dehydrogenases; Androstane-3,17-diol; Androstanes; Biocatalysis; Cell Line; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrone; Humans; Inhibitory Concentration 50; Oxidation-Reduction; Substrate Specificity | 2009 |
Comparative effects of 28-day treatment with the new anti-estrogen EM-800 and tamoxifen on estrogen-sensitive parameters in intact mice.
Topics: 17-Hydroxysteroid Dehydrogenases; Androstenedione; Animals; Atrophy; Benzopyrans; Drug Administration Schedule; Endometrium; Estradiol; Estrogen Antagonists; Estrone; Female; Mice; Mice, Inbred BALB C; Organ Size; Ovariectomy; Propionates; Receptors, Estrogen; Tamoxifen; Testosterone; Uterus; Vagina | 1997 |
Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adrenal Glands; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Benzopyrans; Carcinogens; Cell Division; Drug Screening Assays, Antitumor; Estrogen Antagonists; Estrone; Female; Luteinizing Hormone; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Organ Size; Propionates; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Receptors, Progesterone; Uterus; Vagina | 1997 |
Comparison of the effects of the antiestrogens EM-800 and tamoxifen on the growth of human breast ZR-75-1 cancer xenografts in nude mice.
Topics: Analysis of Variance; Animals; Antineoplastic Agents, Hormonal; Benzopyrans; Breast Neoplasms; Cell Division; Estrogen Antagonists; Estrone; Female; Humans; Mice; Mice, Nude; Ovariectomy; Propionates; Tamoxifen; Transplantation, Heterologous | 1998 |
Comparison of the effects of the new orally active antiestrogen EM-800 with ICI 182 780 and toremifene on estrogen-sensitive parameters in the ovariectomized mouse.
Topics: Animals; Benzopyrans; Estradiol; Estrogen Antagonists; Estrogens; Estrone; Female; Fulvestrant; Mice; Mice, Inbred BALB C; Organ Size; Ovariectomy; Propionates; Receptors, Estrogen; Toremifene; Uterus; Vagina | 1998 |
Effect of dehydroepiandrosterone and the antiestrogen EM-800 on growth of human ZR-75-1 breast cancer xenografts.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Benzopyrans; Breast Neoplasms; Dehydroepiandrosterone; Drug Administration Schedule; Estrogen Antagonists; Estrone; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Ovariectomy; Propionates; Time Factors; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |